
OLD Category: immuno-oncology
January 30, 2019 / Sci Transl Med
A biologic scaffold-associated type 2 immune microenvironment inhibits tumor formation and synergizes with checkpoint immunotherapy
January 30, 2019 / Sci Transl Med.
A biologic scaffold–associated type 2 immune microenvironment inhibits tumor formation and synergizes with checkpoint immunotherapy
January 30, 2019 / Gastroenterology.
CXCR6 Inhibits Hepatocarcinogenesis by Promoting Natural Killer T- and CD4+ T-Cell–Dependent Control of Senescence
January 30, 2019 / Sci Transl Med.
Durable anticancer immunity from intratumoral administration of IL-23, IL-36γ, and OX40L mRNAs
January 29, 2019 / Front Immunol.
CD56dim CD16− Natural Killer Cell Profiling in Melanoma Patients Receiving a Cancer Vaccine and Interferon-α
January 22, 2019 / Neuro Oncol.
Modulation of temozolomide dose differentially affects T-cell response to immune checkpoint inhibition
January 21, 2019 / Nat Nanotechnol
Endosomolytic Polymersomes Increase the Activity of Cyclic Dinucleotide STING Agonists to Enhance Cancer Immunotherapy
January 18, 2019 / Cancer Immunol Res.
Mouse PVRIG Has CD8+ T Cell–Specific Coinhibitory Functions and Dampens Antitumor Immunity
January 17, 2019 / Mol Clin Oncol
Quantitative immunohistochemical assay with novel digital immunostaining for comparisons of PD-L1 antibodies
January 11, 2019 / Proc Natl Acad Sci U S A
Comparison of immune infiltrates in melanoma and pancreatic cancer highlights VISTA as a potential target in pancreatic cancer
January 2, 2019 / J Clin Invest.
Osteopontin mediates glioblastoma-associated macrophage infiltration and is a potential therapeutic target
January 1, 2019 / Cancer Immunol Immunother.